Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system.
Nishioka K, Prayongrat A, Ono K, Onodera S, Hashimoto T, Katoh N, Inoue T, Kinoshita R, Yasuda K, Mori T, Onimaru R, Shirato H, Shimizu S. Nishioka K, et al. Among authors: prayongrat a. J Radiat Res. 2018 Mar 1;59(suppl_1):i63-i71. doi: 10.1093/jrr/rrx083. J Radiat Res. 2018. PMID: 29309691 Free PMC article.
Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.
Kobashi K, Prayongrat A, Kimoto T, Toramatsu C, Dekura Y, Katoh N, Shimizu S, Ito YM, Shirato H. Kobashi K, et al. Among authors: prayongrat a. J Radiat Res. 2018 Mar 1;59(suppl_1):i50-i57. doi: 10.1093/jrr/rry018. J Radiat Res. 2018. PMID: 29538699 Free PMC article.
The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients.
Prayongrat A, Kobashi K, Ito YM, Katoh N, Tamura M, Dekura Y, Toramatsu C, Khorprasert C, Amornwichet N, Alisanant P, Shirato H, Shimizu S. Prayongrat A, et al. Radiother Oncol. 2019 Jun;135:100-106. doi: 10.1016/j.radonc.2019.03.003. Epub 2019 Mar 19. Radiother Oncol. 2019. PMID: 31015154 Free article.
Assessment of the confidence interval in the multivariable normal tissue complication probability model for predicting radiation-induced liver disease in primary liver cancer.
Prayongrat A, Srimaneekarn N, Sriswasdi S, Ito YM, Katoh N, Tamura M, Dekura Y, Toramatsu C, Khorprasert C, Amornwichet N, Alisanant P, Hirata Y, Hayter A, Shirato H, Shimizu S, Kobashi K. Prayongrat A, et al. J Radiat Res. 2021 May 12;62(3):483-493. doi: 10.1093/jrr/rrab011. J Radiat Res. 2021. PMID: 33899102 Free PMC article.
Correction: Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients.
Prayongrat A, Srimaneekarn N, Thonglert K, Khorprasert C, Amornwichet N, Alisanant P, Shirato H, Kobashi K, Sriswasdi S. Prayongrat A, et al. Radiat Oncol. 2023 Mar 15;18(1):53. doi: 10.1186/s13014-023-02212-9. Radiat Oncol. 2023. PMID: 36922889 Free PMC article. No abstract available.
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C, Kitpanit S, Prayongrat A, Kannarunimit D, Netsawang B, Chakkabat C. Lertbutsayanukul C, et al. Among authors: prayongrat a. J Radiat Res. 2018 Jul 1;59(4):446-455. doi: 10.1093/jrr/rry036. J Radiat Res. 2018. PMID: 29750261 Free PMC article. Clinical Trial.
35 results